FCGBP Links Hormonal Imbalance and Hepatic Steatosis in PCOS–NAFLD Comorbidity: An Integrative Bioinformatics and Experimental Study - Top-Institutions - MDSpire

FCGBP Links Hormonal Imbalance and Hepatic Steatosis in PCOS–NAFLD Comorbidity: An Integrative Bioinformatics and Experimental Study

  • By

  • Yao, Yi

  • Si, Min

  • Ding, Hongcheng

  • Cao, Chengcheng

  • Yang, Hua

  • Sun, Qianshu

  • April 14, 2026

  • 0 min

Share

Top Institutions in Obgyn

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Endocrinology
    • Hepatology

  • #2

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, Massachusetts

    Key Differentiators

    • Endocrinology
    • Reproductive Endocrinology

  • #3

    UK Biobank
    UK Biobank

    UK, N/A

    Key Differentiators

    • Data Analysis
    • Epidemiology

  • #4

    Raine Study
    Raine Study

    Perth, Western Australia

    Key Differentiators

    • Longitudinal Studies
    • Adolescent Health

  • #5

    Hispanic Community Health Study/Study of Latinos
    Hispanic Community Health Study/Study of Latinos

    San Diego, California

    Key Differentiators

    • Multicenter Studies
    • Epidemiology

Original Source(s)

FCGBP Links Hormonal Imbalance and Hepatic Steatosis in PCOS–NAFLD Comorbidity: An Integrative Bioinformatics and Experimental Study

  • by Yao, Yi , Si, Min , Ding, Hongcheng , Cao, Chengcheng , Yang, Hua , Sun, Qianshu

  • April 14, 2026

Related Content

Investigation of trends, hot spots and effective therapies for pregnancy outcomes in polycystic ovary syndrome: a bibliometric analysis

Uterine morphology in normogonadotropic anovulation: a comparative study of polycystic ovary syndrome and hypothalamic-pituitary-ovarian dysfunction

AutoPCOS: An Integrated Intelligent Framework for Risk Assessment and Diagnostic Assistance in Polycystic Ovary Syndrome